Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mari Thomas

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
British Journal of Haematology|November 30, 2018
Administration of immunoglobulin G-degrading enzyme of Streptococcus pyogenes (IdeS) for persistent anti-ADAMTS13 antibodies in patients with thrombotic thrombocytopenic purpura in clinical remissionMatthew J Stubbs, Mari Thomas, Chiara Vendramin, et al.
Journal of Thrombosis and Haemostasis : JTH|November 5, 2023
Alterations in the von Willebrand factor/ADAMTS-13 axis in preeclampsiaLucy Neave, Mari Thomas, Rens de Groot, et al.
Research and Practice in Thrombosis and Haemostasis|July 3, 2025
Strategies for anticoagulation in patients with thrombocytopenia and cancer-associated thrombosis (START): design and rationale of the START pilot randomized controlled trialTzu-Fei Wang, Mari Thomas, Andrea Cervi, et al.
British Journal of Haematology|March 29, 2019
Comparison of Rituximab originator (MabThera) to biosimilar (Truxima) in patients with immune-mediated thrombotic thrombocytopenic purpuraMatthew J Stubbs, Ryan Low, Siobhan McGuckin, et al.
British Journal of Haematology|April 17, 2022
The use of obinutuzumab and ofatumumab in the treatment of immune thrombotic thrombocytopenic purpuraAndrew J Doyle, Matthew J Stubbs, Will Lester, et al.
Scientific Reports|July 23, 2024
A randomised controlled trial of plasma exchange compared to standard of care in the treatment of severe COVID-19 infection (COVIPLEX)Nishkantha Arulkumaran, Mari Thomas, Matthew Stubbs, et al.
British Journal of Haematology|July 4, 2023
Acquired Glanzmann's thrombasthenia with IgG and IgA against activated α<sub>IIb</sub> β<sub>3</sub>Adela Constantinescu-Bercu, Sabina McCann, Amjad Hmaid, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2014
Conformational activation of ADAMTS13Kieron South, Brenda M Luken, James T B Crawley, et al.
Obstetric Medicine|February 17, 2025
Interest and barriers to research in obstetric haematology - findings from a national survey in the United KingdomLara N Roberts, Michael Bryan, Jahnavi Daru, et al.
Blood Advances|January 4, 2018
Rituximab prophylaxis to prevent thrombotic thrombocytopenic purpura relapse: outcome and evaluation of dosing regimensJohn-Paul Westwood, Mari Thomas, Ferras Alwan, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
British Journal of Haematology|November 30, 2018
Administration of immunoglobulin G-degrading enzyme of Streptococcus pyogenes (IdeS) for persistent anti-ADAMTS13 antibodies in patients with thrombotic thrombocytopenic purpura in clinical remissionMatthew J Stubbs, Mari Thomas, Chiara Vendramin, et al.
Journal of Thrombosis and Haemostasis : JTH|November 5, 2023
Alterations in the von Willebrand factor/ADAMTS-13 axis in preeclampsiaLucy Neave, Mari Thomas, Rens de Groot, et al.
Research and Practice in Thrombosis and Haemostasis|July 3, 2025
Strategies for anticoagulation in patients with thrombocytopenia and cancer-associated thrombosis (START): design and rationale of the START pilot randomized controlled trialTzu-Fei Wang, Mari Thomas, Andrea Cervi, et al.
British Journal of Haematology|March 29, 2019
Comparison of Rituximab originator (MabThera) to biosimilar (Truxima) in patients with immune-mediated thrombotic thrombocytopenic purpuraMatthew J Stubbs, Ryan Low, Siobhan McGuckin, et al.
British Journal of Haematology|April 17, 2022
The use of obinutuzumab and ofatumumab in the treatment of immune thrombotic thrombocytopenic purpuraAndrew J Doyle, Matthew J Stubbs, Will Lester, et al.
Scientific Reports|July 23, 2024
A randomised controlled trial of plasma exchange compared to standard of care in the treatment of severe COVID-19 infection (COVIPLEX)Nishkantha Arulkumaran, Mari Thomas, Matthew Stubbs, et al.
British Journal of Haematology|July 4, 2023
Acquired Glanzmann's thrombasthenia with IgG and IgA against activated α<sub>IIb</sub> β<sub>3</sub>Adela Constantinescu-Bercu, Sabina McCann, Amjad Hmaid, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2014
Conformational activation of ADAMTS13Kieron South, Brenda M Luken, James T B Crawley, et al.
Obstetric Medicine|February 17, 2025
Interest and barriers to research in obstetric haematology - findings from a national survey in the United KingdomLara N Roberts, Michael Bryan, Jahnavi Daru, et al.
Blood Advances|January 4, 2018
Rituximab prophylaxis to prevent thrombotic thrombocytopenic purpura relapse: outcome and evaluation of dosing regimensJohn-Paul Westwood, Mari Thomas, Ferras Alwan, et al.
Pageof 4